Pharma Lead Generation
Hot Topics: Biosimilars and Cell & Gene Therapy
This month’s hot topics include biosimilars and cell and gene therapy. Read on for highlights of recent news and analysis.
Non-alcoholic steatohepatitis (NASH) is poised to become an even greater epidemic and pharma companies of all sizes are competing to be the first to bring a NASH drug to market. Listen to an in-depth discussion about new and repurposed drug exploration treat NASH, as well as deal making, licensing and partnerships activity for the area.
With so many pharmaceutical companies vying to bring the first NASH drug to market, the industry is seeing the investigation of dozens of new or repurposed drugs, licensing deals, partnerships and M&A activities. Hear this being discussed by experts closely following all the action.
Download the Outlook for NASH Therapy and Market Dynamics slides
Watch the webinar below:
Pharma Lead Generation
This month’s hot topics include biosimilars and cell and gene therapy. Read on for highlights of recent news and analysis.
Topics Biosimilars Cell & Gene Therapy
Scrip: industry news and insights
New Report Highlights Key Industry Trends in Pharmaceutical R&D
Topics Cell & Gene Therapy
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Contact us for product technical and account support.
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: